In diffuse large B-cell lymphoma, Pola-R-CHP maintains progression-free survival at 5-year follow-up.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/5-year-data-diffuse-large-b-cell-lymphoma-treatment-gets-2025a1000r4p?src=rss
Author :
Publish date : 2025-10-08 12:57:00
Copyright for syndicated content belongs to the linked Source.